Sort by
Refine Your Search
-
Country
-
Program
-
Field
-
Genomics working closely with AstraZeneca. You will lead innovation in the renal clinical trials space in this unique collaboration between the Universities of Glasgow and Dundee, the Scottish Renal Research
-
offered full time on a fixed term contract until 27 February 2026 and is funded by AstraZeneca. Only applications received before 12 midday on Thursday 9 May 2024 will be considered. Please quote 171688
-
funded by AstraZeneca. Only applications received before 12 midday on Thursday 9 May 2024 will be considered. Please quote 171688 on all correspondence.
-
), the ETH Zurich (Switzerland), AstraZeneca AB (Sweden) and EATRIS ERIC (Netherlands). ICHB joined this ongoing project with its own budget under the Hop-on Facility (EDITSCD-HOP-ON). Project description
-
Physics, Cambridge Image Analysis (CIA) Group), clinical practice (Dr Tim Rittman, Clinical Neuroscience) with healthcare innovation (Eastern AHSN) and pharmaceutical industry partners (AstraZeneca). Our
-
Physics, Cambridge Image Analysis (CIA) Group), clinical practice (Dr Tim Rittman, Clinical Neuroscience) with healthcare innovation (Eastern AHSN) and pharmaceutical industry partners (AstraZeneca). Our
-
to apply for the EACR-AstraZeneca Postdoctoral Fellowship, for which no more than 8 years can have elapsed since the Ph.D. defence. However, the lab has secured funding for at least 1 year, so the selected
-
(France), the ETH Zurich (Switzerland), AstraZeneca AB (Sweden) and EATRIS ERIC (Netherlands). ICHB will join this ongoing project with its own budget under the Hop-on Facility (EDITSCD-HOP-ON). Project